癌症指數(腫瘤標記)是什麼？ What are Cancer Markers (Tumor Markers)?

一篇看懂報告上的紅字 A Guide to Understanding the Red Flags on Your Report

拿到健檢報告，看到「癌症指數」或「腫瘤標記」出現紅字，總是讓人心頭一驚。但先別慌！這些指數並不像你想的那麼可怕。 Receiving a health report with red flags next to “cancer markers” or “tumor markers” can be startling. But don’t panic! These markers aren’t as frightening as you might think.

簡單來說，癌症指數是癌細胞分泌、或是身體對癌細胞產生反應所製造的物質。這份指南將帶你正確認識這些指標，了解它們真正的用途與限制。 In simple terms, cancer markers are substances secreted by cancer cells or produced by the body in response to them. This guide will help you correctly understand these indicators, their true purpose, and their limitations.

第一章：最重要的觀念：癌症指數不是「癌症診斷書」！ Chapter 1: The Most Important Concept: Cancer Markers are NOT a “Cancer Diagnosis”!

在深入了解各種指數前，請務必記住幾個核心原則： Before we dive into the details of various markers, it’s crucial to remember a few core principles:

癌症指數的「三不原則」 The “Three Don’ts” of Cancer Markers

  • 不等於「一定有」癌症：指數升高，可能是因為良性發炎或其他原因（下面會詳述）。這稱為「偽陽性」。 Don’t assume you “definitely have” cancer: An elevated marker could be due to benign inflammation or other causes (detailed below). This is called a “false positive.”
  • 不等於「一定沒有」癌症：指數正常，不代表絕對沒事。很多早期癌症或不分泌指數的腫瘤，指數也可能是正常的。這稱為「偽陰性」。 Don’t assume you “definitely don’t have” cancer: A normal marker doesn’t mean you’re in the clear. Many early-stage cancers or tumors that don’t secrete markers can have normal levels. This is called a “false negative.”
  • 不適合「用來篩檢」一般人：絕大多數的癌症指數都不適合用來對沒有症狀的一般大眾做癌症篩檢，因為偽陽性太高，會造成不必要的恐慌和過度檢查。 Not suitable for “screening” the general public: The vast majority of cancer markers are not suitable for screening asymptomatic individuals because of the high rate of false positives, which can lead to unnecessary panic and over-testing.

那癌症指數到底有什麼用？ So, What Are Cancer Markers Actually For?

癌症指數最有價值的地方，在於「動態追蹤」。把它想像成一個「趨勢圖」，而不是單張照片。它的主要用途包括： The most valuable use of cancer markers is for “dynamic monitoring.” Think of them as a “trend chart,” not a single photograph. Their main purposes include:

  • 評估預後：治療前指數越高，通常代表腫瘤比較麻煩。 Assessing prognosis: A higher marker level before treatment often indicates a more challenging tumor.
  • 監測治療效果：治療後指數明顯下降，代表治療有效；如果持續上升，可能代表治療無效或產生抗藥性。 Monitoring treatment effectiveness: A significant drop after treatment means the therapy is working. A continued rise may suggest the treatment is ineffective or that resistance has developed.
  • 偵測復發：完成治療後，定期追蹤指數，可以在症狀出現前，就提早發現癌症復發的跡象。 Detecting recurrence: After completing treatment, regular monitoring of the markers can help detect signs of cancer recurrence early, even before symptoms appear.

第二章：常見癌症指數大解析：各指標追蹤什麼癌？ Chapter 2: Common Cancer Markers Explained: Which Cancers Does Each Track?

以下我們來看看幾個健檢報告上最常見的癌症指數，以及它們可能代表的意義。 Below, we’ll look at some of the most common cancer markers on health reports and what they might mean.

腸胃道與胰膽系統 Gastrointestinal and Pancreato-Biliary System

  • CEA (癌胚抗原)：最常用來追蹤大腸癌術後是否復發，但也可能在肺癌、乳癌、胃癌時升高。特別注意：抽菸的人指數會偏高！ CEA (Carcinoembryonic Antigen): Most often used to monitor for colorectal cancer recurrence after surgery, but it can also be elevated in cases of lung, breast, and stomach cancers. Important note: Smokers’ levels are often higher!
  • CA 19-9 (癌症抗原 19-9)：主要與胰臟癌、膽道癌有關。但判讀時有兩大陷阱：(1) 全球有5-10%的人天生就製造不出這個指數。(2) 膽道阻塞（如膽結石）會讓它假性飆高。 CA 19-9 (Carbohydrate Antigen 19-9): Primarily associated with pancreatic and biliary tract cancers. However, there are two major pitfalls in its interpretation: (1) 5-10% of the global population is genetically unable to produce this marker. (2) Biliary obstruction (e.g., gallstones) can cause a false spike.
  • CA 72-4 (癌症抗原 72-4)：主要作為胃癌的輔助監測指標。 CA 72-4 (Carbohydrate Antigen 72-4): Mainly used as an auxiliary monitoring marker for stomach cancer.

肝癌 Liver Cancer

  • AFP (甲型胎兒蛋白)：傳統的肝癌篩檢與追蹤指標，也與睪丸癌有關。但在肝硬化、急性肝炎時也會升高，且約有1/3的肝癌患者AFP是正常的。 AFP (Alpha-fetoprotein): The traditional screening and monitoring marker for liver cancer, also associated with testicular cancer. However, it can also be elevated in liver cirrhosis and acute hepatitis, and about 1/3 of liver cancer patients have normal AFP levels.
  • PIVKA-II (異常凝血酶原)：較新的肝癌指標，與AFP有互補性。兩者結合檢測，可以提高早期肝癌的檢出率。服用抗凝血劑(Warfarin)或缺乏維生素K會讓它假性升高。 PIVKA-II (Protein Induced by Vitamin K Absence or Antagonist-II): A newer liver cancer marker that complements AFP. Testing for both can increase the detection rate of early-stage liver cancer. Taking anticoagulants (Warfarin) or having a Vitamin K deficiency can cause a false elevation.

婦科癌症 Gynecological Cancers

  • CA 125 (癌症抗原 125)：主要用來追蹤卵巢癌。但在子宮內膜異位症、懷孕、月經期間都可能升高，在停經前女性的參考價值較低。 CA 125 (Cancer Antigen 125): Primarily used to monitor ovarian cancer. However, it can also be elevated in cases of endometriosis, pregnancy, and during menstruation, making its reference value lower in premenopausal women.
  • HE4 (人類附睾蛋白 4)：另一個卵巢癌指標，優點是不太會被子宮內膜異位症影響。 HE4 (Human Epididymis Protein 4): Another ovarian cancer marker with the advantage of being less affected by endometriosis.
  • ROMA 指數：結合 CA 125、HE4 和停經狀態的公式，用來評估骨盆腔腫塊為惡性的風險，比單獨看任一指標更準確。 ROMA Index: A formula that combines CA 125, HE4, and menopausal status to assess the risk of a pelvic mass being malignant. It is more accurate than looking at either marker alone.

乳癌 Breast Cancer

  • CA 15-3 / CA 27.29：這兩個是「兄弟」指標，都是用來追蹤轉移性乳癌的治療與復發。它們對早期乳癌不敏感，不適合做篩檢。臨床上擇一檢測即可。 CA 15-3 / CA 27.29: These are “sister” markers used to monitor the treatment and recurrence of metastatic breast cancer. They are not sensitive for early-stage breast cancer and are unsuitable for screening. Clinically, either one is sufficient for monitoring.

攝護腺(前列腺)癌 Prostate Cancer

  • PSA (攝護腺特異性抗原)：目前唯一被廣泛用於攝護腺癌篩檢的指標。但判讀不能只看一個數字，需要更精細的評估：
    • 年齡別參考值：年紀越大，正常值會越高。
    • 游離/總PSA比例 (%fPSA)：當PSA在4-10的灰色地帶時，這個比例很重要。比例越低(<15%)，罹癌風險越高。
    • 良性攝護腺肥大、攝護腺炎、泌尿道感染等都會讓PSA升高。
     PSA (Prostate-Specific Antigen): Currently the only marker widely used for prostate cancer screening. However, interpretation cannot rely on a single number and requires a more detailed assessment:
    • Age-specific reference ranges: The normal range increases with age.
    • Free/Total PSA ratio (%fPSA): This ratio is important when PSA is in the 4-10 gray zone. The lower the ratio (<15%), the higher the risk of cancer.
    • Benign prostatic hyperplasia, prostatitis, and urinary tract infections can all cause PSA levels to rise.

肺癌與其他 Lung Cancer and Others

  • NSE (神經元特異性烯醇化酶)：主要與小細胞肺癌和神經母細胞瘤有關。檢體溶血會造成嚴重假性升高。 NSE (Neuron-Specific Enolase): Primarily associated with small cell lung cancer and neuroblastoma. Hemolysis of the sample can cause a severe false elevation.
  • Cyfra 21-1 (細胞角蛋白片段)：主要用於追蹤非小細胞肺癌，特別是鱗狀癌。 Cyfra 21-1 (Cytokeratin Fragment): Mainly used to monitor non-small cell lung cancer, especially squamous cell carcinoma.
  • SCC (鱗狀上皮細胞癌抗原)：用於追蹤子宮頸癌、肺鱗癌、頭頸癌等。在牛皮癬等皮膚病也會顯著升高。 SCC (Squamous Cell Carcinoma Antigen): Used to monitor cervical cancer, lung squamous cell carcinoma, head and neck cancers, etc. It can also be significantly elevated in skin conditions like psoriasis.
  • β-hCG (人類絨毛膜促性腺激素)：除了驗孕，它也是睪丸癌和滋養層細胞疾病的重要指標。 β-hCG (Human Chorionic Gonadotropin): Besides pregnancy tests, it’s also an important marker for testicular cancer and gestational trophoblastic disease.
  • EBV DNA (EB病毒DNA)：目前被認為是篩檢和追蹤鼻咽癌最準確的指標。 EBV DNA (Epstein-Barr Virus DNA): Currently considered the most accurate marker for screening and monitoring nasopharyngeal carcinoma.
  • NMP22 (核基質蛋白22)：一種尿液檢測，用來輔助診斷與追蹤膀胱癌，但泌尿道發炎、結石也會讓它升高。 NMP22 (Nuclear Matrix Protein 22): A urine test used to assist in the diagnosis and monitoring of bladder cancer, but urinary tract inflammation and stones can also cause it to rise.

第三章：結論：癌症指數是工具，不是最終判決 Chapter 3: Conclusion: Cancer Markers are a Tool, Not a Final Verdict

腫瘤標記是現代醫學的利器，但它是一個充滿變數的工具，絕不是一翻兩瞪眼的神諭。對任何癌症指數的解讀，都必須回歸到最根本的原則： Tumor markers are powerful tools in modern medicine, but they are instruments full of variables, not oracles that give a definitive yes or no answer. The interpretation of any cancer marker must return to the most fundamental principles:

趨勢比單點數值更重要，臨床症狀與影像學檢查才是主角，而病理切片永遠是最終診斷的黃金標準。 The trend is more important than a single value. Clinical symptoms and imaging tests are the main players, and a pathological biopsy is always the gold standard for final diagnosis.

看到報告上的紅字，請不要過度焦慮。它可能只是一個良性的警示，提醒你注意身體的發炎狀況或生活習慣。最好的做法，就是將報告帶給專業的醫師，由醫師結合你的整體狀況，為你做出最正確的判讀與建議。 When you see a red flag on your report, don’t be overly anxious. It may just be a benign warning, prompting you to pay attention to inflammation in your body or your lifestyle habits. The best course of action is to take the report to a professional physician, who will combine it with your overall condition to give you the most accurate interpretation and recommendations.